Drug Profile
Rhenium Re 186 etidronate
Alternative Names: Re 186 HEDPLatest Information Update: 06 Oct 2004
Price :
$50
*
At a glance
- Originator Mallinckrodt Medical
- Developer Mallinckrodt Medical; Memorial Sloan-Kettering Cancer Center; University of Cincinnati
- Class Heavy metals; Non-opioid analgesics; Radiopharmaceuticals; Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer metastases; Cancer pain